Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Vogt‐Weisenhorn D[au]:

Search results

Items: 46

1.

The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4.

Funk N, Munz M, Ott T, Brockmann K, Wenninger-Weinzierl A, Kühn R, Vogt-Weisenhorn D, Giesert F, Wurst W, Gasser T, Biskup S.

Sci Rep. 2019 Mar 14;9(1):4515. doi: 10.1038/s41598-019-40808-y.

2.

Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1.

Weber A, Schwarz SC, Tost J, Trümbach D, Winter P, Busato F, Tacik P, Windhorst AC, Fagny M, Arzberger T, McLean C, van Swieten JC, Schwarz J, Vogt Weisenhorn D, Wurst W, Adhikary T, Dickson DW, Höglinger GU, Müller U.

Nat Commun. 2018 Jul 26;9(1):2929. doi: 10.1038/s41467-018-05325-y.

3.

Determination of thyroid hormones in placenta using isotope-dilution liquid chromatography quadrupole time-of-flight mass spectrometry.

Li ZM, Giesert F, Vogt-Weisenhorn D, Main KM, Skakkebæk NE, Kiviranta H, Toppari J, Feldt-Rasmussen U, Shen H, Schramm KW, De Angelis M.

J Chromatogr A. 2018 Jan 26;1534:85-92. doi: 10.1016/j.chroma.2017.12.048. Epub 2017 Dec 24.

PMID:
29307529
4.

Alterations in neuronal control of body weight and anxiety behavior by glutathione peroxidase 4 deficiency.

Schriever SC, Zimprich A, Pfuhlmann K, Baumann P, Giesert F, Klaus V, Kabra DG, Hafen U, Romanov A, Tschöp MH, Wurst W, Conrad M, Hölter SM, Vogt Weisenhorn D, Pfluger PT.

Neuroscience. 2017 Aug 15;357:241-254. doi: 10.1016/j.neuroscience.2017.05.050. Epub 2017 Jun 13.

PMID:
28627418
5.

The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.

Giesert F, Glasl L, Zimprich A, Ernst L, Piccoli G, Stautner C, Zerle J, Hölter SM, Vogt Weisenhorn DM, Wurst W.

Neurobiol Dis. 2017 Sep;105:179-193. doi: 10.1016/j.nbd.2017.05.013. Epub 2017 May 31.

PMID:
28576705
6.

Analysis of locomotor behavior in the German Mouse Clinic.

Zimprich A, Östereicher MA, Becker L, Dirscherl P, Ernst L, Fuchs H, Gailus-Durner V, Garrett L, Giesert F, Glasl L, Hummel A, Rozman J, de Angelis MH, Vogt-Weisenhorn D, Wurst W, Hölter SM.

J Neurosci Methods. 2018 Apr 15;300:77-91. doi: 10.1016/j.jneumeth.2017.05.005. Epub 2017 May 5.

PMID:
28483715
7.

Determination of thyroid hormones in mouse tissues by isotope-dilution microflow liquid chromatography-mass spectrometry method.

De Angelis M, Giesert F, Finan B, Clemmensen C, Müller TD, Vogt-Weisenhorn D, Tschöp MH, Schramm KW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 15;1033-1034:413-420. doi: 10.1016/j.jchromb.2016.08.037. Epub 2016 Aug 26.

PMID:
27649501
8.

Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.

Vogt Weisenhorn DM, Giesert F, Wurst W.

J Neurochem. 2016 Oct;139 Suppl 1:8-26. doi: 10.1111/jnc.13670. Epub 2016 Jun 27. Review.

9.

Conditional Reduction of Adult Born Doublecortin-Positive Neurons Reversibly Impairs Selective Behaviors.

Garrett L, Zhang J, Zimprich A, Niedermeier KM, Fuchs H, Gailus-Durner V, Hrabě de Angelis M, Vogt Weisenhorn D, Wurst W, Hölter SM.

Front Behav Neurosci. 2015 Nov 12;9:302. doi: 10.3389/fnbeh.2015.00302. eCollection 2015.

10.

Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics.

de Angelis MH, Nicholson G, Selloum M, White J, Morgan H, Ramirez-Solis R, Sorg T, Wells S, Fuchs H, Fray M, Adams DJ, Adams NC, Adler T, Aguilar-Pimentel A, Ali-Hadji D, Amann G, André P, Atkins S, Auburtin A, Ayadi A, Becker J, Becker L, Bedu E, Bekeredjian R, Birling MC, Blake A, Bottomley J, Bowl M, Brault V, Busch DH, Bussell JN, Calzada-Wack J, Cater H, Champy MF, Charles P, Chevalier C, Chiani F, Codner GF, Combe R, Cox R, Dalloneau E, Dierich A, Di Fenza A, Doe B, Duchon A, Eickelberg O, Esapa CT, El Fertak L, Feigel T, Emelyanova I, Estabel J, Favor J, Flenniken A, Gambadoro A, Garrett L, Gates H, Gerdin AK, Gkoutos G, Greenaway S, Glasl L, Goetz P, Da Cruz IG, Götz A, Graw J, Guimond A, Hans W, Hicks G, Hölter SM, Höfler H, Hancock JM, Hoehndorf R, Hough T, Houghton R, Hurt A, Ivandic B, Jacobs H, Jacquot S, Jones N, Karp NA, Katus HA, Kitchen S, Klein-Rodewald T, Klingenspor M, Klopstock T, Lalanne V, Leblanc S, Lengger C, le Marchand E, Ludwig T, Lux A, McKerlie C, Maier H, Mandel JL, Marschall S, Mark M, Melvin DG, Meziane H, Micklich K, Mittelhauser C, Monassier L, Moulaert D, Muller S, Naton B, Neff F, Nolan PM, Nutter LM, Ollert M, Pavlovic G, Pellegata NS, Peter E, Petit-Demoulière B, Pickard A, Podrini C, Potter P, Pouilly L, Puk O, Richardson D, Rousseau S, Quintanilla-Fend L, Quwailid MM, Racz I, Rathkolb B, Riet F, Rossant J, Roux M, Rozman J, Ryder E, Salisbury J, Santos L, Schäble KH, Schiller E, Schrewe A, Schulz H, Steinkamp R, Simon M, Stewart M, Stöger C, Stöger T, Sun M, Sunter D, Teboul L, Tilly I, Tocchini-Valentini GP, Tost M, Treise I, Vasseur L, Velot E, Vogt-Weisenhorn D, Wagner C, Walling A, Weber B, Wendling O, Westerberg H, Willershäuser M, Wolf E, Wolter A, Wood J, Wurst W, Yildirim AÖ, Zeh R, Zimmer A, Zimprich A; EUMODIC Consortium, Holmes C, Steel KP, Herault Y, Gailus-Durner V, Mallon AM, Brown SD.

Nat Genet. 2015 Sep;47(9):969-978. doi: 10.1038/ng.3360. Epub 2015 Jul 27.

11.

A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.

Zhang J, Götz S, Vogt Weisenhorn DM, Simeone A, Wurst W, Prakash N.

Neurobiol Dis. 2015 Oct;82:32-45. doi: 10.1016/j.nbd.2015.05.015. Epub 2015 Jun 3.

PMID:
26049140
12.

Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition.

Vogl AM, Brockmann MM, Giusti SA, Maccarrone G, Vercelli CA, Bauder CA, Richter JS, Roselli F, Hafner AS, Dedic N, Wotjak CT, Vogt-Weisenhorn DM, Choquet D, Turck CW, Stein V, Deussing JM, Refojo D.

Nat Neurosci. 2015 Feb;18(2):239-51. doi: 10.1038/nn.3912. Epub 2015 Jan 12.

PMID:
25581363
13.

Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.

Giesert F, Hofmann A, Bürger A, Zerle J, Kloos K, Hafen U, Ernst L, Zhang J, Vogt-Weisenhorn DM, Wurst W.

PLoS One. 2013 May 10;8(5):e63778. doi: 10.1371/journal.pone.0063778. Print 2013.

14.

Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb.

Glasl L, Kloos K, Giesert F, Roethig A, Di Benedetto B, Kühn R, Zhang J, Hafen U, Zerle J, Hofmann A, de Angelis MH, Winklhofer KF, Hölter SM, Vogt Weisenhorn DM, Wurst W.

Exp Neurol. 2012 May;235(1):214-27. doi: 10.1016/j.expneurol.2012.01.002. Epub 2012 Jan 11.

PMID:
22265660
15.

Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.

Rolyan H, Scheffold A, Heinrich A, Begus-Nahrmann Y, Langkopf BH, Hölter SM, Vogt-Weisenhorn DM, Liss B, Wurst W, Lie DC, Thal DR, Biber K, Rudolph KL.

Brain. 2011 Jul;134(Pt 7):2044-56. doi: 10.1093/brain/awr133. Epub 2011 Jun 14.

PMID:
21672962
16.

LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.

Piccoli G, Condliffe SB, Bauer M, Giesert F, Boldt K, De Astis S, Meixner A, Sarioglu H, Vogt-Weisenhorn DM, Wurst W, Gloeckner CJ, Matteoli M, Sala C, Ueffing M.

J Neurosci. 2011 Feb 9;31(6):2225-37. doi: 10.1523/JNEUROSCI.3730-10.2011.

17.

A powerful transgenic tool for fate mapping and functional analysis of newly generated neurons.

Zhang J, Giesert F, Kloos K, Vogt Weisenhorn DM, Aigner L, Wurst W, Couillard-Despres S.

BMC Neurosci. 2010 Dec 31;11:158. doi: 10.1186/1471-2202-11-158.

18.

Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.

Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, Vanbrabant M, Haddad D, Frezza C, Mandemakers W, Vogt-Weisenhorn D, Van Coster R, Wurst W, Scorrano L, De Strooper B.

EMBO Mol Med. 2009 May;1(2):99-111. doi: 10.1002/emmm.200900006.

19.

DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments.

Pham TT, Giesert F, Röthig A, Floss T, Kallnik M, Weindl K, Hölter SM, Ahting U, Prokisch H, Becker L, Klopstock T, Hrabé de Angelis M, Beyer K, Görner K, Kahle PJ, Vogt Weisenhorn DM, Wurst W.

Genes Brain Behav. 2010 Apr;9(3):305-17. doi: 10.1111/j.1601-183X.2009.00559.x. Epub 2009 Dec 17.

20.

Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation.

Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, Lämmermann K, Brunner B, Kurz-Drexler A, Vogel F, Reichert AS, Bouman L, Vogt-Weisenhorn D, Wurst W, Tatzelt J, Haass C, Winklhofer KF.

J Biol Chem. 2009 Aug 21;284(34):22938-51. doi: 10.1074/jbc.M109.035774. Epub 2009 Jun 22.

21.

Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1.

Waak J, Weber SS, Waldenmaier A, Görner K, Alunni-Fabbroni M, Schell H, Vogt-Weisenhorn D, Pham TT, Reumers V, Baekelandt V, Wurst W, Kahle PJ.

FASEB J. 2009 Aug;23(8):2478-89. doi: 10.1096/fj.08-125153. Epub 2009 Mar 10.

PMID:
19276172
22.

Cellular repair strategies in Parkinson's disease.

Winner B, Vogt-Weisenhorn DM, Lie CD, Blümcke I, Winkler J.

Ther Adv Neurol Disord. 2009 Jan;2(1):51-60. doi: 10.1177/1756285608100324.

23.

Novel allele of crybb2 in the mouse and its expression in the brain.

Ganguly K, Favor J, Neuhäuser-Klaus A, Sandulache R, Puk O, Beckers J, Horsch M, Schädler S, Vogt Weisenhorn D, Wurst W, Graw J.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1533-41. doi: 10.1167/iovs.07-0788.

PMID:
18385073
24.

Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain.

Saarimäki-Vire J, Peltopuro P, Lahti L, Naserke T, Blak AA, Vogt Weisenhorn DM, Yu K, Ornitz DM, Wurst W, Partanen J.

J Neurosci. 2007 Aug 8;27(32):8581-92.

25.

Creatine improves health and survival of mice.

Bender A, Beckers J, Schneider I, Hölter SM, Haack T, Ruthsatz T, Vogt-Weisenhorn DM, Becker L, Genius J, Rujescu D, Irmler M, Mijalski T, Mader M, Quintanilla-Martinez L, Fuchs H, Gailus-Durner V, de Angelis MH, Wurst W, Schmidt J, Klopstock T.

Neurobiol Aging. 2008 Sep;29(9):1404-11. Epub 2007 Apr 9.

PMID:
17416441
26.

Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1.

Görner K, Holtorf E, Waak J, Pham TT, Vogt-Weisenhorn DM, Wurst W, Haass C, Kahle PJ.

J Biol Chem. 2007 May 4;282(18):13680-91. Epub 2007 Mar 1.

27.

Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain.

Blak AA, Naserke T, Saarimäki-Vire J, Peltopuro P, Giraldo-Velasquez M, Vogt Weisenhorn DM, Prakash N, Sendtner M, Partanen J, Wurst W.

Dev Biol. 2007 Mar 1;303(1):231-43. Epub 2006 Nov 10.

28.

Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain.

Di Benedetto B, Hitz C, Hölter SM, Kühn R, Vogt Weisenhorn DM, Wurst W.

J Comp Neurol. 2007 Jan 20;500(3):542-56.

PMID:
17120291
29.

Molecular characterization, structure and developmental expression of Megane bHLH factor.

Guimera J, Vogt Weisenhorn D, Echevarría D, Martínez S, Wurst W.

Gene. 2006 Aug 1;377:65-76. Epub 2006 Mar 18.

PMID:
16644143
30.

Embryonic expression profile of phospholipid hydroperoxide glutathione peroxidase.

Schneider M, Vogt Weisenhorn DM, Seiler A, Bornkamm GW, Brielmeier M, Conrad M.

Gene Expr Patterns. 2006 Jun;6(5):489-94. Epub 2006 Feb 2.

PMID:
16458079
31.

Progressive loss of the spongiotrophoblast layer of Birc6/Bruce mutants results in embryonic lethality.

Hitz C, Vogt-Weisenhorn D, Ruiz P, Wurst W, Floss T.

Genesis. 2005 Jun;42(2):91-103. Erratum in: Genesis. 2005 Dec;43(4):216.

PMID:
15887267
32.

Effects of Wnt1 signaling on proliferation in the developing mid-/hindbrain region.

Panhuysen M, Vogt Weisenhorn DM, Blanquet V, Brodski C, Heinzmann U, Beisker W, Wurst W.

Mol Cell Neurosci. 2004 May;26(1):101-11.

PMID:
15121182
33.

Expression of neurochondrin in the developing and adult mouse brain.

Istvánffy R, Vogt Weisenhorn DM, Floss T, Wurst W.

Dev Genes Evol. 2004 Apr;214(4):206-9. Epub 2004 Mar 9.

PMID:
15007648
34.

The proton/amino acid cotransporter PAT2 is expressed in neurons with a different subcellular localization than its paralog PAT1.

Rubio-Aliaga I, Boll M, Vogt Weisenhorn DM, Foltz M, Kottra G, Daniel H.

J Biol Chem. 2004 Jan 23;279(4):2754-60. Epub 2003 Nov 3.

35.

FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals.

Trokovic R, Trokovic N, Hernesniemi S, Pirvola U, Vogt Weisenhorn DM, Rossant J, McMahon AP, Wurst W, Partanen J.

EMBO J. 2003 Apr 15;22(8):1811-23.

36.

Therapy of neurodegenerative diseases using neurotrophic factors: cell biological perspective.

Brodski C, Vogt Weisenhorn DM, Dechant G.

Expert Rev Neurother. 2002 May;2(3):417-26. doi: 10.1586/14737175.2.3.417.

PMID:
19810873
37.

mPet-1, a mouse ETS-domain transcription factor, is expressed in central serotonergic neurons.

Pfaar H, von Holst A, Vogt Weisenhorn DM, Brodski C, Guimera J, Wurst W.

Dev Genes Evol. 2002 Feb;212(1):43-6. Epub 2002 Jan 31.

PMID:
11875656
38.

Coupling of cAMP/PKA and MAPK signaling in neuronal cells is dependent on developmental stage.

Vogt Weisenhorn DM, Roback LJ, Kwon JH, Wainer BH.

Exp Neurol. 2001 May;169(1):44-55.

PMID:
11312557
39.

Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns.

Hof PR, Glezer II, Condé F, Flagg RA, Rubin MB, Nimchinsky EA, Vogt Weisenhorn DM.

J Chem Neuroanat. 1999 Feb;16(2):77-116. Review.

PMID:
10223310
40.

Beta-adrenergic and fibroblast growth factor receptors induce neuronal process outgrowth through different mechanisms.

Kwon JH, Vogt Weisenhorn DM, Downen M, Ruan K, Roback L, Joshi H, Wainer BH.

Eur J Neurosci. 1998 Sep;10(9):2776-89.

PMID:
9758148
41.

The onset of parvalbumin-expression in interneurons of the rat parietal cortex depends upon extrinsic factor(s).

Vogt Weisenhorn DM, Celio MR, Rickmann M.

Eur J Neurosci. 1998 Mar;10(3):1027-36.

PMID:
9753170
42.

Calretinin-immunoreactivity during postnatal development of the rat isocortex: a qualitative and quantitative study.

Schierle GS, Gander JC, D'Orlando C, Ceilo MR, Vogt Weisenhorn DM.

Cereb Cortex. 1997 Mar;7(2):130-42.

PMID:
9087821
43.

Temporal and spatial appearance of the membrane cytoskeleton and perineuronal nets in the rat neocortex.

Wintergerst ES, Vogt Weisenhorn DM, Rathjen FG, Riederer BM, Lambert S, Celio MR.

Neurosci Lett. 1996 May 17;209(3):173-6.

PMID:
8736638
44.

Calretinin-immunoreactivity in organotypic cultures of the rat cerebral cortex: effects of serum deprivation.

Vogt Weisenhorn DM, Weruaga-Prieto E, Celio MR.

Exp Brain Res. 1996 Feb;108(1):101-12.

PMID:
8721158
46.

Calretinin-positive Cajal-Retzius cells persist in the adult human neocortex.

Belichenko PV, Vogt Weisenhorn DM, Myklóssy J, Celio MR.

Neuroreport. 1995 Oct 2;6(14):1869-74.

PMID:
8547587

Supplemental Content

Loading ...
Support Center